Search Results 121-130 of 16755 for GLP-1 agonists
Participation eligibility · Diabetes mellitus (type 1). · Diabetes mellitus type 2 if taking metformin or GLP-1 agonist treatment (exenatide, liraglutide, ...
If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. ... You may report side effects to ...
Concurrent use of any non-insulin glucose-lowering agent other than metformin (including GLP-1 agonists, Symlin, DPP-4 inhibitors, SGLT-2 inhibitors ...
Early glucagon-like peptide-1 receptor agonist use after myocardial infarction in patients with type 2 diabetes. Int J Cardiol. 2026 Feb 15; 445:134042 Epub ...
Research shows that metabolic surgery and GLP-1 medications are both effective therapies for treating obesity. Medications typically result in a 10% loss of ...
... GLP-1 agonists) management and determine when to refer for interventional treatment. Research. During your core rotation, you will have time with one to two ...
Contraindications to GLP-1 receptor agonist therapy as per Tirzepatide (Zepbound ®) label. Currently enrolled in another clinical study involving an ...
Assessment of Gastric Content Using Gastric Ultrasound in Patients on Glucagon-Like Peptide-1 Receptor Agonists Before Anesthesia. Anesth Analg. 2025 Oct 1 Epub ...
Have had any exposure to GLP-1 analogs, GLP-1 receptor agonists (including dual GLP-1/GIP receptor agonists) or other related compounds within the prior 3 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.